Grenville Strategic Royalty and Joint Venture Partners Announce US$300,000 Royalty Agreement with MedWorxs

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Grenville Strategic Royalty and Joint Venture Partners Announce US$300,000 Royalty Agreement with MedWorxs

Follow-on investment of US$250,000 in Factor 75

TORONTO, ONTARIO--(Marketwired - April 18, 2017) - Grenville Strategic Royalty Corp. (TSX VENTURE:GRC) ("Grenville" or the "Company") today announced it has signed a royalty purchase agreement with MedWorxs LLC ("MedWorxs") to provide US$150,000 in growth capital. Grenville's investment partners, Foregrowth Holdco Inc. and Darwin Strategic Royalty Corp., invested alongside Grenville, for a total commitment from the three parties of US$300,000 to MedWorxs.

MedWorxs is a privately-held, Denver-based company that provides inpatient and ambulatory software solutions to healthcare facilities through its proprietary cloud-based, software-as-a-service platform. Its service offering includes electronic health records, ambulatory health records, revenue cycle management software, financial and management software.

In addition to the investment in MedWorxs, Grenville and its joint venture partners also announced a follow-on investment of US$250,000 in Factor 75, a healthy meal delivery company. Grenville committed US$125,000 to the follow-on investment based on the exceptional growth demonstrated by Factor 75 during the first quarter of 2017.

"MedWorxs is an excellent example of a company that fits our go-forward investment strategy. It is a recurring revenue business with an established growth strategy, run by highly experienced experts in the target market," said Steve Parry, Chief Executive Officer of Grenville. "Similarly, Factor 75 has demonstrated the high growth potential of their fitness-based meal service again with a highly talented team and proven execution capability."

About MedWorxs LLC

MedWorxs is a privately-held, international leader in inpatient and ambulatory software solutions. Its cloud based technology is modern in design, delivering the right features for its customer base. MedWorxs is software, people and expertise dedicated to helping the organization meet regulatory commitments, reduce costs, errors and improve the quality of care.

About Factor 75

Based in Chicago and founded in 2012, Factor 75 is dedicated to optimizing people's lives by giving them more energy, time and a fresh perspective on how to live. The Factor 75 approach takes care of planning, preparing and delivering healthy, nutritious meals to customers nationwide across the United States.

About Grenville

Based in Toronto, Grenville Strategic Royalty Corp. is a publicly-traded royalty company that makes investments in established businesses with revenues of up to $50 million dollars. Grenville generates revenues from royalty payments and buyouts from contracts. The non-dilutive royalty financing structure offered by Grenville competes directly with traditional equity to meet the long-term financing needs of companies on more attractive commercial terms.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Grenville Strategic Royalty Corp.
Steven Parry
Chief Executive Officer
(416) 777-0383

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).